IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
作者： Douglas F. Easton , Bruce A.J. Ponder , Alison M. Dunning , Ali Al-Zahrani , Manjinder S. Sandhu
DOI: 10.1093/HMG/DDI398
关键词:
摘要: … We found that IGFBP3 variants that were associated with lower IGFBP3 levels were also associated with an increased risk of breast cancer, suggesting that IGFBP3 may be protective. …
oup.com
paperity.org
oxfordjournals.org参考文章(31)
Luben R, Welch A, Day N, Oakes S, Khaw Kt, Bingham S, Wareham N, EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. British Journal of Cancer. pp. 95- 103 ,(1999)
Julie S. Hartell, Jeffrey S Miller, Deepali Sachdev, Douglas Yee, Shu Lian Li, Yoko Fujita-Yamaguchi, A Chimeric Humanized Single-Chain Antibody against the Type I Insulin-like Growth Factor (IGF) Receptor Renders Breast Cancer Cells Refractory to the Mitogenic Effects of IGF-I Cancer Research. ,vol. 63, pp. 627- 635 ,(2003)
Douglas Burtrum, Zhenping Zhu, Dan Lu, Donna Marie Anderson, Marie Prewett, Daniel S Pereira, Rajiv Bassi, Rashed Abdullah, Andrea T Hooper, Henry Koo, Xenia Jimenez, Danielle Johnson, Robin Apblett, Paul Kussie, Peter Bohlen, Larry Witte, Daniel J Hicklin, Dale L Ludwig, None, A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth in Vivo Cancer Research. ,vol. 63, pp. 8912- 8921 ,(2003)
Eva S. Schernhammer, Susan E. Hankinson, David J. Hunter, Marie J. Blouin, Michael N. Pollak, Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. International Journal of Cancer. ,vol. 107, pp. 60- 64 ,(2003) , 10.1002/IJC.11358
Katja Eggermann, Hartmut A. Wollmann, Jürgen Tomiuk, Michael B. Ranke, Peter Kaiser, Thomas Eggermann, Screening for mutations in the promoter and the coding region of the IGFBP1 and IGFBP3 genes in Silver-Russell syndrome patients. Human Heredity. ,vol. 49, pp. 123- 128 ,(1999) , 10.1159/000022858
Suresh Mishra, Avrahram Raz, Liam J. Murphy, Insulin-Like Growth Factor Binding Protein-3 Interacts with Autocrine Motility Factor/Phosphoglucose Isomerase (AMF/PGI) and Inhibits the AMF/PGI Function Cancer Research. ,vol. 64, pp. 2516- 2522 ,(2004) , 10.1158/0008-5472.CAN-03-2877
Alison J. Butt, Janet L. Martin, Kristie A. Dickson, Fiona McDougall, Sue M. Firth, Robert C. Baxter, Insulin-Like Growth Factor Binding Protein-3 Expression Is Associated with Growth Stimulation of T47D Human Breast Cancer Cells: The Role of Altered Epidermal Growth Factor Signaling The Journal of Clinical Endocrinology and Metabolism. ,vol. 89, pp. 1950- 1956 ,(2004) , 10.1210/JC.2003-030914
M Harrela, H Koistinen, J Kaprio, M Lehtovirta, J Tuomilehto, J Eriksson, L Toivanen, M Koskenvuo, P Leinonen, R Koistinen, M Seppälä, Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. Journal of Clinical Investigation. ,vol. 98, pp. 2612- 2615 ,(1996) , 10.1172/JCI119081
Jaya M. Satagopan, Robert C. Elston, Optimal two-stage genotyping in population-based association studies Genetic Epidemiology. ,vol. 25, pp. 149- 157 ,(2003) , 10.1002/GEPI.10260
M. S. Gill, A. J. Whatmore, V. Tillman, A. White, G. M. Addison, D. A. Price, P. E. Clayton, Urinary IGF and IGF binding protein-3 in children with disordered growth Clinical Endocrinology. ,vol. 46, pp. 483- 492 ,(1997) , 10.1046/J.1365-2265.1997.1670981.X